This study investigated the influence of bio logical and technical factors on variations of global and regional cerebral metabolic rate of glucose (CMR g lc ) measured with 2-['8F]fluoro-2-d eoxY-D-glucose (['8F]FDG). Twelve male volunteers (22-40 years) were
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teredo Both technical and biological factors have been implicated as causes of this variability. The purpose of our investigation was to deter mine the relative influences of technical and biolog ical factors on the variability of the regional and global cerebral metabolic rate of glucose in normal subjects. Table 2 lists the biological and technical factors in volved with the measurement of CMR g lc using PET.
MATERIALS AND METHODS

Operational equation
Some of these factors, such as nonradioactive blood glu cose concentration, brain radioactivity, and two inte grals, are present in the operational equation shown be low:
where Cgl = nonradioactive blood glucose concentration; CB(n = brain radioactivity; k" k2' k3' k4 = rate con stants of cerebral glucose metabolism, with k l = 0.102 min-',k2 = 0.130 min-',k3 = 0.062 min-',k4 = 0.0068 min- with and T = time of imaging; C 1 , C2, C3 = amplitudes of pSF]FDG blood activity curve; and AI' A2, A3 = rate con stants of [,sF]FDG blood clearance.
Subjects
To investigate the influences of all of these factors on the variability of cerebral glucose metabolism, 12 healthy, right-handed, normal male volunteers (22-40 years of age) were studied. Exclusion criteria included significant neu rologic, psychiatric, or metabolic disease; hospitalization within 1 month prior to the start of the study; alcoholism, cigarette smoking, or drug abuse; and use of any medi cation within 7 days prior to study entrance. After signing a consent form, all volunteers had a com plete medical history, physical examination, a standard 12-lead electrocardiogram, a chest radiograph, and a se ries of laboratory tests including hematologic profile, blood chemistry, urinalysis, and urine toxicology.
PET imaging
PET imaging was obtained on days 0, 3, and 10 on all volunteers and on day 7 in six of them. Therefore, 42 studies were obtained in this normal popUlation.
All subjects were confined overnight prior to the PET study. The next morning they had a light breakfast, low in glucose and caffeine, 2-4 h prior to intravenous injection of PSF]FDG. In a quiet room with dim light, two intra venous lines were inserted. One on the dorsum of a hand was maintained with saline and heparin, and covered with a warming pad at a comfortable temperature (44°C), for arterialization of venous blood. The other, in the opposite forearm, was maintained with a saline drip for tracer in jection. Earplugs were then placed and the subjects blind folded 5 min prior to tracer injection and so maintained for the next 35-40 min.
In each study, the volunteers were injected with 4-5 mCi (148-185 MBq) of [ l sF]FDG. [JSF]FDG was synthe sized from [JSF]fluoride, produced in a biomedical cyclo tron (MC-16F, Scanditronix, Uppsala, Sweden) by the (p,n) reaction on 98% enriched pSO]water, according to the method of Hamacher et al. (1986) . The radiochemical purity of the final product was determined in every study using thin-layer chromatography or high-performance liq uid chromatography on an amino column eluted with aqueous acetonitrile, and was always >98%. All prepa rations were determined to be sterile and apyrogenic.
Arterialized venous blood sampling was begun imme diately after tracer injection and continued for 90 min. Prior to imaging, a previously made thermoplastic face mask was placed and the subject positioned on the scan ner table. The inferior orbitomeatal line was marked on the mask using orthogonal laser beams. This line was used as reference for precise repositioning in repeat stud ies. The above conditions, including the hour of injection, were reproduced as closely as possible for repeat studies in the same individual. Imaging was started 45-60 min after radiopharmaceutical injection using a NeuroECAT PET scanner (Cn Ortec; Oak Ridge, TN, U.S.A.) with an in-plane resolution of 8 mm. The CMRglc in mg min -I Huang et al. (1980) . Twenty-four regions of interest (ROIs) were selected at various levels of the brain (as identified in Tables 3-5 ) and their metabolic rates com pared from one study to another in the same individual and among individuals.
Statistical analysis of the data consisted of multiple steps, as follows: The global CMRglc was obtained from the mean of the 24 regional CMRglc values of all 42 stud ies. Both the global and the regional CMRglc values were tested for homogeneity of their variances by the Bartlett Box F test (1937 Box F test ( ,1953 and the Cochran test (1941) .
To estimate intrasubject variance, all regional and glob al CMRglc values from the 12 individuals (36 measure ments for each ROn were used to calculate the mean, standard deviation, and coefficient of variation of three repeat measurements. This resulted in 288 regional and 12 global values for the mean, standard deviation, and coef ficient of variation. The mean of these values was ob tained by averaging all of the data from the 12 volunteers.
To estimate intersubject variance, all regional and glob al CMRglc values from the 12 individuals (36 measure ments for each ROI) were used to calculate the mean, standard deviation, and coefficient of variation. Group differences of means were tested by the mUltiple range test of Tukey (1949) and by the repeated-measures anal ysis of variance, using 36 measurements.
Simple correlation analysis was used to assess the cor relation of the global metabolic rate of 42 studies with all biological and technical factors and also to correlate each factor with all of the others.
Factor analysis was used to investigate the fundamen tal correlations among different brain regions and to as sess the contribution of the regional CMRglc values to the variance of the global CMRglc' For this purpose, a corre lation matrix was constructed from the simple correla tions between the CMRglc values. Factors were extracted from the matrix by the principal component method and were varimax rotated to achieve the best separation of potential clusters.
In summary, we used 36 measurements (data from days 0, 3, and 10) for variance analysis and 42 measurements (data from days 0, 3, 7, and 10) for correlations and factor analysis.
RESULTS
Figures 1-3 illustrate how the absolute CMRglc
varied with the region chosen and with the individ ual for the baseline (day 0), the combination of days 3 and 7 added together, and day 10 studies, respec tively. The magnitudes of the individual and re gional fluctuations of glucose metabolism were sim ilar in these three figures.
The variability of the same region in the same subject from one study to another was also ana lyzed. Of the 288 regions investigated, 196 (68%) had coefficients of variation between 0 and 10%, 78 (27%) regions had coefficients of variation between 11 and 20%; and only 5% of the regions showed coefficients >20%, as illustrated by the histogram in Fig. 4 .
The intrasubject variance of both global and re gional CMRglc, in 36 measurements, is presented in Table 3 . The mean regional metabolic rates ranged from 6.30 to 11.09 mg min -I 100 g-I. The coeffi cients of variation for the various regions ranged from 7.2 to 12.9%, with an average of 8.4%. The mean global metabolic rate was 8.64 mg min -I 100 g-I, with a coefficient of variation of 7.1%.
The combined intersubject and intrasubject vari ance of both regional and global metabolic rates of glucose in 42 measurements is shown in Table 4 . The mean regional metabolic rates ranged from 6.26 to 10.95 mg min -1 100 g -I, close to the intrasubject data presented in Table 3 . However, the coeffi cients of variation for the various regions ranged from 12.1 to 23.2%, with an average of 16.6%, dem onstrating considerably larger variations when in tersubject comparison was made. The global meta bolic rate of 8.56 mg min -I 100 g-I was not differ ent from the global value in Table 3 , but again its ROI coefficient of variation of 13.8% was much larger than for the intrasubject data. Table 5 displays F values and p values for significant differences be tween any two studies (days 0, 3,7, and 10). There was no significant difference in the variances of all of these studies at the 0. 05 level.
A tendency for higher metabolic rates in the first study was noted, but it did not occur in every sub ject. Therefore, the effect of nonfamiliarity with the study (Metz et aI., 1989) could not be confirmed in this normal population. Table 6 displays the left to right ratios for all re gions included in our investigation, on each day, and for all days together. The overall mean was 1.01, with a coefficient of variation of 7.7%.
The correlations between the CMRglc and the var ious technical and biological factors are shown in Table 7 . There was correlation among the compo nents of the operational equation (nonradioactive blood glucose concentration, brain radioactivity, two integrals, numerator, and denominator), except for the nonradioactive blood glucose concentration. There was no correlation between the CMRglc and any of the technical and biological factors investi gated. The coefficients of variation of the numera tor and denominator of the operational equation were 34. 6 and 32.6%, respectively, and occurred always in the same direction. Despite that, the in trasubject and intersubject coefficients of variation were 7. 1 and 13.8%, respectively, as mentioned be fore (Tables 3 and 4) .
N one of the technical and biological factors in volved in our investigation could explain the vari ance of the CMRglc• We then used factor analysis to verify whether or not we could identify regions or groups of regions where the variance was more prominent, with the hope of better understanding the reason for these variances. Factor analysis was able to separate the regions into two factors (Table  8 ). Use of one factor could account for 70% of the observed variance. The highest loadings for this factor included caudate, putamen, thalamus, cingu late, frontal cortex, and temporal cortex. Use of two factors could account for 80% of the variance. The same structures as in the single factor analysis had the highest loadings. A closer look at factor I showed that the thalamus and putamen influenced the variance the most (Table 8 ).
DISCUSSION
Variances in brain glucose metabolism in normal subjects have been reported by several investiga- tors. Huang et al. (1980) found a 18% coefficient of variation for the mean CMRglc in the gray matter, with the intersubject metabolic rates ranging from 4.83 to 8.96 mg min-1 100 g-l. Mazziotta et al. (1981) and Heiss et al. (1984) reported coefficients of variation as high as 27 and 33.8%, respectively, for regional glucose metabolism. Duara et al. (1984) investigated the effect of age on the CMRglc• They found coefficients of variation as high as 25% in several regions, with global metabolic rates ranging from 2 to 7 mg min -1 100 g -1 even between indi viduals of similar ages. However, these variations did not correlate with age. In a comparison of rest ing and activated states, coefficients of variation of 24 and 14%, respectively, were observed (Duara et aI., 1987) . We did not use a standardized task or activation to try to decrease variability. Our normal volunteers could use their imagination and thought processes at will. Despite that, our coefficient of variation of 13.8% was similar to the 14% found by Duara et al. (1987) with a standardized activation protocol. More recently, Tyler et al. (1988) investi gated 20 subjects, five of them scanned twice, and observed mean hemispheric metabolic rates for gray matter ranging from 31.4 to 59 ).Lmol min -1 100 g -1. The mean regional coefficients of variation were 11.4 and 16.9% for intra-and intersubject vari ations, respectively. Clark et al. (1985) , using arte rialized venous blood, eyes closed, and acoustic stimulus, found that 74.8% of the total variability was due to individual differences. The variances de scribed here for three or four repeat studies in 12 normal male volunteers are similar to some of the results cited above. Although most of our regional variations had coefficients below 10%, 14 regions showed coefficients of variation >20%. The explanation for the variances found in our study and in the literature has been a matter of de bate. Strother et al. (1987) of methodological factors on regional cerebral glu cose metabolism, and Grady et al. (1989) , compar ing results from different PET scanners, found that the metabolic rates increased with higher spatial resolution. However, such difference would not ac count for the variability in our study, since the same scanner was used for all subjects. More recently, other technical factors, such as the size of the ROJ (Grady et aI., 1990) , measurement noise in plasma curves (Chen et aI., 1990) , and manual versus auto mated blood sampling (Matthew et al. 1990 ), have been recognized as having some influence on the variability. On the other hand, Kanno et al. (1990) , using H21 5 0, have demonstrated that the physiolog ical fluctuation in regional CBF has a coefficient of variation of 4-5%. In their view, this represents the intrinsic, lower limit of variability achievable with current technology. We have investigated the roles of technical and biological factors on the variance of our results, us-TABLE 5. Repeated-measures analysis of variance of global and regional metabolic rates of glucose (CMRg1c) by the day of investigation (days 0, 3,7, and 10)
(1) L. cerebellum (1) 0.08 0.92 (12) L. temporal (II) 0.00 1.00
(2) R. cerebellum (1) ing analysis of variance and covariance and factor analysis. We have considered the nonradioactive blood glucose concentration, the three rate con stants of eSp]PDG blood clearance, and the hour of tracer injection as biologic factors. The nonradioac tive blood glucose concentration is clearly depen dent on diet and metabolism, and was always in the lower end of the normal range, due to the low glu cose diet used by all volunteers in our protocol. We could not demonstrate any correlation between the nonradioactive blood glucose concentration and variations in cerebral glucose metabolism, either because our protocol was effective in maintaining the nonradioactive blood glucose concentrations practically constant for repeat studies, or because the operational equation accounts for differences in nonradioactive blood glucose levels (Huang et al., 1981) .
The three rate constants of eSp]PDG blood clear ance were also considered as biologic factors, since they are related to compartmental distribution, up take, and metabolism of glucose. As we expected, these three constants correlated with each other and with their respective amplitudes. Importantly, however, they did not correlate with the CMR g lc.
To avoid possible influences of circadian rhythms of hormonal metabolism on the CMR g 1c (Landgraf et al., 1982; Bartlett et al., 1988; Room and Tiele mans, 1989) , we tried to reproduce the hour of tracer injection as closely as possible for repeat studies in the same individual. However, since we studied three individuals per day, there was always a time interval of about 3 h between the first and the last study. A slight trend for variation of the meta bolic rate of glucose with the hour of tracer injec tion was noticed, but it was not significant enough to explain the variability encountered. Other possi ble sources of variation, such as sex and handed ness (Gur et aI., 1982; Baxter et aI., 1987) or age and estrogen level fluctuations (Wong et aI., 1988) , were not addressed in our investigation. To reduce the number of variables on the CMR g lc, we intention ally used only young, right-handed, male volun teers.
Brain radioactivity is the result of a combination of biologic and technical factors such as blood flow and metabolism, tracer amount, and adequacy of bolus injection. Both biologic and technical compo nents seem to be important as determinants of brain radioactivity, despite the fact that no significant correlation was found between brain radioactivity and CMR g lc • Amplitudes of tracer blood activity are related to the adequacy of tracer injection and blood sam pling. Recently, Matthew et ai. (1990) reported an intrasubject mean difference of 7.2% for CBF mea surements using H21 5 0, but found no difference be tween manual and automated arterial sampling. Their data suggest that manual sampling, as in our study, should not account for possible fluctuations in the CMR g lc, and indeed we found no correlation between glucose metabolic rates and the amplitudes of tracer blood activity.
Blood sampling, be it manual or automated, arte rial or arterialized venous blood, is a very important technical factor that might influence the variability of cerebral glucose metabolism. Several investiga tors are using arterialized venous blood (Huang et aI., 1980; Heiss et aI., 1984; Clark et aI., 1985; Du ara et aI., 1987; Tyler et aI., 1988) , as we did in our investigation. Using arterialized venous blood and manual sampling, we have been unable to correlate the variability of the CMR g lc to the technical factors that are closely dependent on blood sampling, such as the time of peak blood activity, and the ampli tudes of tracer blood activity. It is unlikely, there fore, that, using arterial blood or automated sam pling, theoretically more precise techniques, any correlation with cerebral glucose metabolism fluc tuations would have been found.
J Cereb Blood Flow Metab. Vol. 12, No.2, 1992 The absence of correlation with integrals 1 and 2 of the operational equation may be accounted for on the basis of the findings of Huang et ai. (1981) that the equation is relatively insensitive to changes within the normal range. As presented above, both the numerator and denominator condense several factors already discussed, except for the nonradio active blood glucose concentration and brain radio activity. The numerator and denominator were found to vary always in the same direction, a find ing already described by Huang et ai. (198 1) . Their variations, of 34.6 and 32.6%, would thus tend to cancel each other, but we continued to find intra subject and intersubject variations of 7. 1 and 13.8%, respectively. This meant that other factors, unaccounted for in the equation and in our analysis, were causing the variability.
We tried to uncover these factors using covari ance and factor analysis. Several investigators have reported on the covariance and correlations of brain regions. Horwitz et ai. (1984) found correlations of symmetrical regions and the correlation between primary somatosensory and premotor association areas. Horwitz and Rapoport (1988) found signifi cant partial correlations and reference ratio corre lations, in a study of 60 normals who presented a coefficient of variation of 22.5%. In a study of stim ulated, deprived, and vegetative subjects, Strother et ai. (1988) found two significant covariance pat terns. In the present investigation, factor analysis was able to disclose a group of regions with distinct covariances of cerebral glucose metabolism. This group included the putamen, thalamus, caudate nu cleus, cingulate gyrus, frontal cortex, and temporal cortex. The fact that most of the variance could be explained by a single factor suggested a biological, intrinsic mechanism as its source. Among the re gions or structures included in this factor, the puta men and thalamus accounted for most of the vari ance. It is well known that there are several basal metabolic processes continuously going on in the brain, all of which have their own variability and require glucose as a substrate (Kennedy, 1985) . It is also evident that this group comprises regions or structures involved with multiple complex func tions such as autonomic motor control, visceral in formation, perception of stimuli, attention, behav ior, emotions, and motivation. These complex brain functions, in addition to the basal cerebral meta bolic processes, with their own intrinsic variability, may be the best explanation for the variance in the CMR g lc encountered in our investigation.
In summary, our data suggest that the major source of variance associated with measurement of CMRglc is cerebral in nature. This implies that methods that control biological activity, such as standardized activation protocols, may be useful in reducing any observed variation. Our data also sug gest that the overall variance must be carefully quantified and taken into consideration before drawing conclusions on investigations using eSF]FDG and PET imaging.
